Search by Drug Name or NDC

    NDC 00169-4525-94 WEGOVY 0.25 mg/.5mL Details

    WEGOVY 0.25 mg/.5mL

    WEGOVY is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is SEMAGLUTIDE.

    Product Information

    NDC 00169-4525
    Product ID 0169-4525_3a4f9f29-6860-4f16-9310-bea0726b2b0f
    Associated GPIs 6125207000D520
    GCN Sequence Number 082355
    GCN Sequence Number Description semaglutide PEN INJCTR 0.25MG/0.5 SUBCUT
    HIC3 J8E
    HIC3 Description ANTI-OBESITY GLUCAGON-LIKE PEPTIDE-1 RECEP AGONIST
    GCN 49748
    HICL Sequence Number 044675
    HICL Sequence Number Description SEMAGLUTIDE
    Brand/Generic Brand
    Proprietary Name WEGOVY
    Proprietary Name Suffix n/a
    Non-Proprietary Name semaglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 0.25
    Active Ingredient Units mg/.5mL
    Substance Name SEMAGLUTIDE
    Labeler Name Novo Nordisk
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215256
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-4525-94 (00169452594)

    NDC Package Code 0169-4525-94
    Billing NDC 00169452594
    Package 4 SYRINGE, PLASTIC in 1 CARTON (0169-4525-94) / .5 mL in 1 SYRINGE, PLASTIC (0169-4525-90)
    Marketing Start Date 2021-06-05
    NDC Exclude Flag N
    Pricing Information N/A